Magnetic resonance imaging following interStim reg: An institutional experience with imaging safety and patient satisfaction

Neurourology and Urodynamics

Volumn 30, Issue 8, 2011, Pages 1486-1488

  Chermansky, Christopher J ^a   Krlin, Ryan M ^a,b   Holley, Thomas D ^a,b   Woo, Howard H ^b   Winters, J Christian ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

interstim reg; magnetic resonance imaging; neurostimulation; patient satisfaction; safety

Indexed keywords

ARTICLE; BRAIN; CERVICAL SPINE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEVICE SAFETY; HUMAN; IMPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT SAFETY; PATIENT SATISFACTION; PELVIC EXAMINATION; PULSE GENERATOR; RETROSPECTIVE STUDY;

ELECTRIC STIMULATION THERAPY; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HUMANS; IMPLANTABLE NEUROSTIMULATORS; LOUISIANA; MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PATIENT SATISFACTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; URINARY INCONTINENCE, URGE;

EID: 80054816185     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21147     Document Type: Article

References (20)

1. Medtronic Inc Urology. Available at:.
2. Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology 2000; 56: 87-91.
3. Jonas U, Fowler CJ, Chancellor MB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 2001; 165: 15-19.
4. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 2007; 178: 2029-34.
5. Wallace PA, Lane FL, Noblett KL,. Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Obstet Gynecol 2007; 197: 96.e1-e5.
6. Food and Drug Administration, Center for Devices and Radiological Health. Available at:.
7. Medtronic Inc Urology. Available at:.
8. Kanal E, Shellock FG,. Policies, guidelines, and recommendations for MR imaging safety and patient management. SMRI Safety Committee. J Magn Reson Imaging 1992; 2: 247-48.
9. Achenbach S, Moshage W, Diem B, et al. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997; 134: 467-73.
10. Shellock FG, Morisoli S, Kanal E,. MR procedures and biomedical implants, materials, and devices: 1993 update. Radiology 1993; 189: 587-99.
11. Food and Drug Administration, Center for Devices and Radiological Health. Original InterStim Submission. Available at:.
12. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004; 43: 1315-24.
13. Shellock FG, Hatfield M, Simon BJ, et al. Implantable spinal fusion stimulator: assessment of MR safety and artifacts. J Magn Reson Imaging 2000; 12: 214-23.
14. Shellock FG, Cosendai G, Park SM, Nyenhuis JA,. Implantable microstimulator: magnetic resonance safety at 1.5 Tesla. Invest Radiol 2004; 39: 591-99.
15. Rezai AR, Finelli D, Nyenhuis JA, et al. Neurostimulation systems for deep brain stimulation: in vitro evaluation of magnetic resonance imaging-related heating at 1.5 tesla. J Magn Reson Imaging 2002; 15: 241-50.
16. Elkelini MS, Hassouna MM,. Safety of MRI at 1.5 Tesla in patients with implanted sacral nerve stimulator. Eur Urol 2006; 50: 311-16.
17. Rezai AR, Baker KB, Tkach JA, et al. Is magnetic resonance imaging safe for patients with neurostimulation systems used for deep brain stimulation? Neurosurgery 2005; 57: 1056-62.
18. Luechinger R, Duru F, Scheidegger MB, et al. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001; 24: 199-205.
19. Baker KB, Tkach JA, Nyenhuis JA, et al. Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging 2004; 20: 315-20.
20. Beamon C, Desai A, Sutherland S, et al. MRI and InterStimâsurvey analysis of active implanters. Neurourol Urodyn 2009; 28: 135-36.